论文部分内容阅读
目的比较热毒宁与利巴韦林治疗小儿急性上呼吸道感染的临床效果。方法选取2015年12月-2016年12月医院收治的小儿急性上呼吸道感染患儿80例作为研究对象,随机分为研究组和对照组各40例。研究组使用热毒宁进行治疗,对照组使用利巴韦林进行治疗,观察2组患儿的治疗效果,比较2组患儿鼻塞流涕停止时间、咳嗽停止时间、咽部充血停止时间及退热时间。结果研究组总有效率为97.5%明显高于对照组的80.0%,差异有统计学意义(χ2=6.134,P<0.05)。研究组鼻塞流涕停止时间、咳嗽停止时间、咽部充血停止时间及退热时间均明显短于对照组,差异均有统计学意义(P<0.05)。结论热毒宁治疗小儿急性上呼吸道感染具有效果好、安全性高的特点,在短时间内可快速地缓解患儿的临床症状,值得在临床中广泛推广和使用。
Objective To compare the clinical effects of Renduining and Ribavirin in the treatment of pediatric acute upper respiratory tract infection. Methods Eighty children with acute upper respiratory tract infection in children admitted from December 2015 to December 2016 in our hospital were selected as study subjects and randomly divided into study group (40 cases) and control group (40 cases). The study group was treated with Rendoxin, while the control group was treated with ribavirin. The therapeutic effect of the two groups of children was observed. The stop time of nasal obstruction, the stop time of cough, the stop time of throat congestion, Hot time. Results The total effective rate of the study group was 97.5%, which was significantly higher than that of the control group (χ2 = 6.134, P <0.05). The stopping time of nasal obstruction, the stopping time of cough, the stopping time of pharyngeal congestion and the antipyretic time were all shorter in the study group than those in the control group (P <0.05). Conclusion Renduining treatment of children with acute upper respiratory tract infection has a good effect, high safety features, in a short time can quickly alleviate the clinical symptoms of children, it is worth widely in clinical use and use.